Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 May;33(5):567–570. doi: 10.1038/bjc.1976.91

Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.

R R Joseph, D Belpomme, G Mathé
PMCID: PMC2024950  PMID: 776199

Full text

PDF
567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belpomme D., Dantchev D., Du Rusquec E., Grandjon D., Huchet R., Pouillart P., Schwarzenberg L., Amiel J. L., Mathé G. T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia. Biomedicine. 1974 Mar;20(2):109–118. [PubMed] [Google Scholar]
  2. Carosella E. D., Mochanko K., Braun M. Rosette-forming T cells in human peripheral blood at different ages. Cell Immunol. 1974 May;12(2):323–325. doi: 10.1016/0008-8749(74)90085-9. [DOI] [PubMed] [Google Scholar]
  3. Greenberg A. H., Hudson L., Shen L., Roitt I. M. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell. Nat New Biol. 1973 Mar 28;242(117):111–113. doi: 10.1038/newbio242111a0. [DOI] [PubMed] [Google Scholar]
  4. Gutterman J. U., Mavligit G. M., Reed R. C., Hersh E. M. Immunochemotherapy of human cancer. Semin Oncol. 1974 Dec;1(4):409–423. [PubMed] [Google Scholar]
  5. HALPERN B. N., BIOZZI G., STIFFEL C., MOUTON D. [Effect of stimulation of the reticuloendothelial system by inoculation of the Calmette-Guerin bacillus on the development of the atypical Guerin T-S epithelioma in the rat]. C R Seances Soc Biol Fil. 1959;153:919–923. [PubMed] [Google Scholar]
  6. MacLennan C. M. Immunosuppression and immunostimulation in acute leukaemia. Proc R Soc Med. 1975 Apr;68(4):216–217. doi: 10.1177/003591577506800403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697–699. doi: 10.1016/s0140-6736(69)92648-8. [DOI] [PubMed] [Google Scholar]
  8. Mathé G., Kamel M., Dezfulian M., Halle-Pannenko O., Bourut C. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy. Cancer Res. 1973 Sep;33(9):1987–1997. [PubMed] [Google Scholar]
  9. Nathanson L. Use of BCG in the treatment of human neoplasms: a review. Semin Oncol. 1974 Dec;1(4):337–350. [PubMed] [Google Scholar]
  10. OLD L. J., BENACERRAF B., CLARKE D. A., CARSWELL E. A., STOCKERT E. The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 1961 Oct;21:1281–1300. [PubMed] [Google Scholar]
  11. Weksler M. E., Hütteroth T. H. Impaired lymphocyte function in aged humans. J Clin Invest. 1974 Jan;53(1):99–104. doi: 10.1172/JCI107565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wybran J., Fudenberg H. Editorial: How clinically useful is T and B cell quantitation? Ann Intern Med. 1974 Jun;80(6):765–767. doi: 10.7326/0003-4819-80-6-765. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES